{"disease":{"id":"cardiac-transplantation","name":"cardiac transplantation"},"drugs":{"marketed":[{"drug_id":"valganciclovir","indication_name":"Prevention of CMV Disease After Cardiac Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valcyte","generic_name":"VALGANCICLOVIR","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":70,"revenue":null,"mechanism":"Valcyte works by inhibiting the replication of cytomegalovirus DNA through its action as a nucleoside analog DNA polymerase inhibitor."},{"drug_id":"ppsv23","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with chronic heart disease, including congestive heart failure, coronary artery disease, or cardiac transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ppsv23","generic_name":"ppsv23","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"ganciclovir","indication_name":"Prevention of CMV Disease After Cardiac Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07096973","title":"Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Hochgebirgsklinik Davos","has_results":false},{"nct_id":"NCT06813443","title":"Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT02672683","title":"Non Invasive Detection of Cardiac Allograft Rejection by Circulating microRNAs","phase":"","overall_status":"COMPLETED","enrollment_count":461,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02503566","title":"Assessment of Cardiac Allograft Vasculopathy by Optical Coherence Tomography","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Institute for Clinical and Experimental Medicine","has_results":false},{"nct_id":"NCT00716573","title":"Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07379294","title":"Soft Foam Dressings for Pressure Injury Prevention of Cardiac Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Shih,Wen-Chi","has_results":false},{"nct_id":"NCT03145441","title":"Intraoperative Use of Extracorporeal Cytokine Adsorption During Orthotopic Heart Transplantation","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Semmelweis University","has_results":false},{"nct_id":"NCT02904278","title":"Novel Mobile Device Application to Improve Adherence","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05904678","title":"Anatomical and Functional Assessment of Ex-vivo Coronary Perfusion","phase":"","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Fondation Hôpital Saint-Joseph","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}